Dan-Ning Hu Selected Research

Diabetic Retinopathy (Retinopathy, Diabetic)

2/2015	IL-1β induces IL-6 production in retinal Müller cells predominantly through the activation of p38 MAPK/NF-κB signaling pathway.
1/2015	Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
1/2015	Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dan-Ning Hu Research Topics

Disease

20	Uveal melanoma 01/2022 - 11/2006
16	Neoplasms (Cancer) 01/2019 - 10/2002
15	Melanoma (Melanoma, Malignant) 10/2018 - 10/2002
7	Macular Degeneration (Age-Related Maculopathy) 01/2015 - 09/2006
6	Cataract (Cataracts) 12/2017 - 10/2002
6	Myopia 12/2017 - 12/2006
5	Proliferative Vitreoretinopathy 01/2016 - 02/2005
4	Uveitis 12/2023 - 01/2015
4	Pterygium 01/2017 - 10/2009
3	Hypoxia (Hypoxemia) 03/2017 - 01/2015
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2015 - 01/2015
3	Vitiligo 08/2014 - 07/2004
2	Endophthalmitis (Ophthalmia) 12/2023 - 08/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2018 - 01/2013
2	Retinal Diseases 03/2017 - 01/2015
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2016 - 03/2010
2	Eye Diseases (Eye Disease) 01/2015 - 01/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 10/2011
2	Autoimmune Diseases (Autoimmune Disease) 12/2012 - 09/2010
2	Phototoxic Dermatitis (Phototoxicity) 01/2010 - 05/2007
2	Glaucoma 10/2002 - 08/2002
1	Anterior Uveitis 12/2023
1	Prostatic Neoplasms (Prostate Cancer) 10/2016
1	Blister (Bulla) 10/2016
1	Keratoconus 10/2015
1	Necrosis 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Purpura 01/2015
1	Retinal Detachment (Retinal Detachments) 01/2015
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2015
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015

Drug/Important Bio-Agent (IBA)

10	Retinal Pigments (Pigments, Visual)IBA 05/2018 - 09/2006
8	Proteins (Proteins, Gene)FDA Link 11/2018 - 11/2007
6	Cytochromes c (Cytochrome c)IBA 11/2018 - 04/2010
6	Messenger RNA (mRNA)IBA 10/2018 - 11/2007
5	Matrix Metalloproteinases (MMPs)IBA 12/2017 - 10/2009
5	ZeaxanthinsIBA 01/2015 - 01/2013
5	Retinaldehyde (Retinal)IBA 04/2012 - 05/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2017 - 10/2002
4	LuteinIBA 01/2016 - 01/2010
4	MicroRNAs (MicroRNA)IBA 03/2013 - 04/2009
3	CaspasesIBA 11/2018 - 04/2010
3	buteinIBA 11/2018 - 08/2012
3	Conditioned Culture MediaIBA 10/2018 - 10/2002
3	Tissue Inhibitor of Metalloproteinase-3IBA 12/2017 - 05/2014
3	Tissue Inhibitor of Metalloproteinase-2IBA 12/2017 - 05/2014
3	MelatoninIBA 03/2017 - 08/2009
3	CurcuminIBA 01/2017 - 03/2010
3	Caspase 9IBA 12/2016 - 04/2010
3	norcantharidinIBA 10/2016 - 04/2010
3	Interleukin-6 (Interleukin 6)IBA 02/2015 - 09/2010
3	Caspase 3 (Caspase-3)IBA 01/2015 - 04/2010
3	Melanins (Melanin)IBA 04/2010 - 11/2007
2	CytokinesIBA 12/2023 - 12/2012
2	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2020
2	Neutralizing AntibodiesIBA 01/2022 - 11/2021
2	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 11/2018 - 01/2015
2	Tissue Inhibitor of Metalloproteinase-1IBA 12/2017 - 05/2014
2	p38 Mitogen-Activated Protein KinasesIBA 02/2013 - 01/2013
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2013 - 01/2011
2	AntioxidantsIBA 04/2010 - 01/2010
2	iridalIBA 08/2009 - 05/2005
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2009 - 02/2005
1	AntibodiesIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	FlavonoidsIBA 05/2018
1	fisetinIBA 05/2018
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 12/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2017
1	Protein Isoforms (Isoforms)IBA 12/2017
1	Dihydrotachysterol (AT 10)IBA 03/2017
1	chrysinIBA 12/2016
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016
1	XanthophyllsIBA 01/2015
1	Therapeutic UsesIBA 01/2015
1	meso-zeaxanthinIBA 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Vancomycin FDA LinkGeneric 08/2014
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2014
1	CoagulaseIBA 08/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2014
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2014
1	Small Interfering RNA (siRNA)IBA 03/2013
1	Peptide Hydrolases (Proteases)FDA Link 02/2013
1	Annexin A5IBA 01/2013
1	Ethidium (Ethidium Bromide)IBA 01/2013
1	SurvivinIBA 01/2013
1	ApigeninIBA 01/2013
1	PhytochemicalsIBA 01/2013

Therapy/Procedure

2	Intravitreal Injections 12/2023 - 01/2022
2	Transplantation 08/2014 - 07/2004
2	Aftercare (After-Treatment) 01/2013 - 04/2010
1	Corneal Transplantation (Keratoplasty) 10/2015
1	Penetrating Keratoplasty 10/2015
1	Lasers (Laser) 10/2015
1	Intraocular Injections 01/2015
1	Therapeutics 01/2013